Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors



Rating:

Share or cite this content

Citations should be made in the following way:
C. De Pace (Foggia, Italy), D. Lacedonia (Foggia, Italy), G. Scioscia (Foggia, Italy), A. Del Colle (Foggia, Italy), E. Minenna (Foggia, Italy), M. De Carlo (Foggia, Italy), M. Palumbo (Foggia, Italy), M. Foschino-Barbaro (Foggia, Italy). Impact of viral load on mortality in hospitalized patients affected by Covid-19 infection.. 804

Member's Comments

No comment yet.

Related content which might interest you: One-year follow up of patients hospitalized for acute exacerbation of COPD related to viral infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Mortality among patients admitted for viral lower respiratory tract infections – a seasonal cohort study Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Varicella-Zoster virus pneumonia in an adult population. Has the mortality decreased? Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 Enhanced severity of virus associated asthma exacerbations is not associated with delayed viral clearance and increased viral load Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005 Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants. Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018 Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020 Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Respiratory viral infection in immunocompromised patients Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Serum Albumin-Globulin ratio reversal predicts morbidity in patients hospitalized for Influenza A(H1N1) infection. Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 Prolonged viral RNA shedding in patients with COVID-19 infection Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Respiratory syncitial virus infection in hospitalized Brazilian infants with acute lower respiratory disease: incidence and associated factors Source: Eur Respir J 2005; 26: Suppl. 49, 628s Year: 2005 Risk factors and outcomes of severe influenza pneumonia with bacterial co-infection in critically ill patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017 Statin use is associated with reduced mortality after respiratory viral infection Source: ERJ Open Res, 7 (1) 00365-2020; 10.1183/23120541.00365-2020 Year: 2021 Viral infection in adult hospitalized with community acquired pneumonia Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Prevalence of virus infections in patients with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 599s Year: 2004 Study of bacterial, viral and fungal agents affecting pediatric patients with lower respiratory tract infection admitted to PICU in Alexandria Source: Eur Respir J 2003; 22: Suppl. 45, 144s Year: 2003 Incidence, genetic variability and clinical characteristics of nosocomial infection by respiratory virus in children Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008 Factors associated and attack rate in adenovirus infection among children with chronic respiratory disease Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011 The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Impact of bacterial co-infection with COVID-19 on morbidity and mortality Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021